Scandal of the poison pen-pushers * The Case Against EBM * Generic Liability

[pharmaguy]

December 2, 2012

(Also see the Pharmaguy SM Pioneer Daily: http://bit.ly/pgSMdaily)

[Contents: Scandal of the poison pen-pushers * The Case Against Evidence-Based Medicine * Generic Liability]

Scandal of the poison pen-pushers

Mail Online

How doctors and patients are kept in the dark about potentially dangerous everyday drugs

amiflu is supposed to be the miracle flu drug. Patients across the UK rely on it. In medicine cupboards everywhere patients have eagerly stockpiled it, and in some winters there has even been talk of rationing.

The Government itself has spent £500 million on stockpiling the drug to keep the country from collapse in the wake of a bird-flu epidemic, since it’s supposed to reduce the risk of pneumonia and death.

And yet for all we know, Tamiflu might be no better than paracetamol: because Roche, the company making it, still withholds vital information on the risks and benefits from researchers, doctors and patients.

Click here to read more...

Read these related articles:

• Tamiflu, Relenza May or May Not Protect Expectant Mothers from Flu

--------------------------

Time to abandon evidence based medicine?

YouTube

A talk by Prof David Healy from the Institute of Psychological Medicine and Clinical Neurosciences at Cardiff University. The talk was presented at the Cardiff University School of Psychology on 26th November 2012.

Comment: Dr. Healy makes a compelling case that we're all being bamboozled, doctors included, by corrupted "evidence" driven solely by corporate greed. Welcome to "medical science".

Click here to view the video...

Read this related article:

• Will Healthcare be Rationed or Rational? – pdf

Listen to these related podcasts:

• Side Effects: Death - A Former Lilly Insider Blows the Whistle on Criminal Activity in Sweden
• FDA's User-Unfriendly Adverse Event Reporting System: Outdated in the New Transparent World of Social Media

--------------------------

Supremes To Review Lawsuits Over Generic Flaws

Pharmalot

In a move that has generic drugmakers concerned, the US Supreme Court has agreed to consider whether personal injury lawsuits can be filed for alleged flaws in the design of their medications. At issue is whether federal law prempts such claims from proceeding in state courts and if generic drugmakers can be held liable if they decline to withdraw their medicines.

Click here for more...

Read this related article:

• Branded Pharma Wages War Against Generic and OTC Medicines: COLCRYS vs. colchicine Case Study

--------------------------

(Also see the Pharmaguy SM Pioneer Daily: http://bit.ly/pgSMdaily)